MD1592B2 - Cristale de enzimă reticulate şi aplicarea lor în dispozitiv extracorporal, în biosensor şi pentru obţinerea produsului selectat - Google Patents

Cristale de enzimă reticulate şi aplicarea lor în dispozitiv extracorporal, în biosensor şi pentru obţinerea produsului selectat

Info

Publication number
MD1592B2
MD1592B2 MD94-0406A MD940406A MD1592B2 MD 1592 B2 MD1592 B2 MD 1592B2 MD 940406 A MD940406 A MD 940406A MD 1592 B2 MD1592 B2 MD 1592B2
Authority
MD
Moldova
Prior art keywords
reticulated
crystals
enzym
obtaining
selected product
Prior art date
Application number
MD94-0406A
Other languages
English (en)
Russian (ru)
Inventor
Manuel A. Navia
Nancy L. St.Clair
Original Assignee
Vertex Pharmaceuticals Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharmaceuticals Incorporated filed Critical Vertex Pharmaceuticals Incorporated
Publication of MD1592B2 publication Critical patent/MD1592B2/ro

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • C07K5/06121—Asp- or Asn-amino acid the second amino acid being aromatic or cycloaliphatic
    • C07K5/0613—Aspartame
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6448—Elastases, e.g. pancreatic elastase (3.4.21.36); leukocyte elastase (3.4.31.37)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C12N9/82—Asparaginase (3.5.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001—Enzyme electrodes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001—Enzyme electrodes
    • C12Q1/002—Electrode membranes
    • C12Q1/003—Functionalisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Liquid Crystal Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Piezo-Electric Or Mechanical Vibrators, Or Delay Or Filter Circuits (AREA)

Abstract

Invenţia se referă la cristale de enzimă reticulate care manifestă rezistenţă la protează. Prezenta invenţie prevede utilizarea cristalelor reticulate de enzimă în dispozitive extracorporale, biosensori pentru detectarea analitului şi în calitate de catalizator enzimic pentru obţinerea produsului selectat.Esenţa invenţiei constă în faptul că cristalele de enzimă se reticulează cu un agent multifuncţional de reticulare, iar cristalele reticulate de enzimă posedă rezistenţă la proteoliza exogenă, astfel încât cristalele reticulate menţionate păstrează cel puţin 91% din activitatea lor iniţială după incubare pentru 3 ore în prezenţa pronazei (PronaseTM), în aceleaşi condiţii forma solubilă nereticulată de enzimă cristalizabilă, pierde cel puţin 94 % din activitatea sa iniţială.Rezultatul invenţiei constă în includerea în cristalele de enzimă a legăturilor intermoleculare transversale, care ameliorează semnificativ proprietăţile acestor cristale ceea ce permite extinderea domeniului de utilizare a lor în medicină, în condiţii industriale rigide şi depozitarea lor îndelungată cu menţinerea activităţii.
MD94-0406A 1990-08-03 1994-07-14 Cristale de enzimă reticulate şi aplicarea lor în dispozitiv extracorporal, în biosensor şi pentru obţinerea produsului selectat MD1592B2 (ro)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56228090A 1990-08-03 1990-08-03

Publications (1)

Publication Number Publication Date
MD1592B2 true MD1592B2 (ro) 2001-01-31

Family

ID=24245600

Family Applications (1)

Application Number Title Priority Date Filing Date
MD94-0406A MD1592B2 (ro) 1990-08-03 1994-07-14 Cristale de enzimă reticulate şi aplicarea lor în dispozitiv extracorporal, în biosensor şi pentru obţinerea produsului selectat

Country Status (26)

Country Link
EP (2) EP0550450B1 (ro)
JP (2) JPH05508549A (ro)
AT (2) ATE323158T1 (ro)
AU (1) AU662104B2 (ro)
BR (1) BR9106732A (ro)
CA (1) CA2087730C (ro)
CZ (1) CZ12393A3 (ro)
DE (2) DE69133258T2 (ro)
DK (2) DK0861888T3 (ro)
ES (2) ES2263187T3 (ro)
FI (1) FI120099B (ro)
HK (2) HK1012411A1 (ro)
HU (2) HUT65904A (ro)
IE (1) IE912767A1 (ro)
IL (1) IL99046A (ro)
LT (1) LT3366B (ro)
LV (1) LV10304B (ro)
MD (1) MD1592B2 (ro)
NO (1) NO930360L (ro)
PT (1) PT98564B (ro)
RU (1) RU2124052C1 (ro)
SG (1) SG70966A1 (ro)
SK (1) SK283185B6 (ro)
TJ (1) TJ210R3 (ro)
UA (1) UA27035C2 (ro)
WO (1) WO1992002617A1 (ro)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932212A (en) * 1996-05-24 1999-08-03 Altus Biologics, Inc. Crosslinked protein crystal formulations and their use as catalysts in organic solvents
AU4738197A (en) * 1996-09-24 1998-04-17 Altus Biologics Inc. Crosslinked protein crystals as universal separation media
US6140475A (en) * 1997-04-11 2000-10-31 Altus Biologics Inc. Controlled dissolution crosslinked protein crystals
US6500933B1 (en) 1997-09-05 2002-12-31 Altus Biologics Inc. Methods of preparing carbohydrate crosslinked glycoprotein crystals
DE69839563D1 (de) 1997-09-05 2008-07-10 Altus Pharmaceuticals Inc Kohlenhydrat-vernetzte glykoproteinkristalle
US6979561B1 (en) 1998-10-09 2005-12-27 Gilead Sciences, Inc. Non-homogeneous systems for the resolution of enantiomeric mixtures
GB9823334D0 (en) 1998-10-23 1998-12-23 Darwin Discovery Ltd Enzyme coupling
WO2002070646A2 (en) * 2001-02-16 2002-09-12 Ibex Technologies Matrix stabilized enzyme crystals and methods of use
US7241272B2 (en) 2001-11-13 2007-07-10 Baxter International Inc. Method and composition for removing uremic toxins in dialysis processes
EP1699921B1 (en) * 2004-01-01 2009-11-04 Council of Scientific and Industrial Research;an Indian Reg. body incorporated under Reg. of Societies Act (Act XXI of 1860) A method for the preparation of cross linked protein crystals
AU2005227090B2 (en) 2004-03-22 2010-12-09 Abbott Laboratories Gmbh Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
RU2385736C2 (ru) 2004-10-14 2010-04-10 Элтус Фармасьютикалз Инк. Композиции, содержащие липазу, протеазу и амилазу, предназначенные для лечения недостаточности поджелудочной железы
KR101555058B1 (ko) 2005-07-29 2015-09-22 애보트 래버러토리즈 게엠베하 살균된 판크레아틴 분말의 제조방법
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US8852904B2 (en) * 2009-05-22 2014-10-07 Sanyo Foods Co., Ltd. Protein complex having activity catalyzing asymmetric oxidation reaction and process for producing the same
WO2011034822A1 (en) * 2009-09-15 2011-03-24 Bhami Shenoy Protein a crystals and cross-linked crystals and methods of use thereof
JP5740754B2 (ja) 2010-08-26 2015-07-01 アイシン精機株式会社 酵素結晶固定化電極及び酵素結晶固定化電極の製造方法、並びに酵素結晶固定化電極を備えるバイオ電池及びバイオセンサー
US11077238B2 (en) 2013-06-07 2021-08-03 Allena Pharmaceuticals, Inc. Compositions, methods, and devices for dialysis
WO2016126970A1 (en) 2015-02-04 2016-08-11 Abbvie Inc. Pharmaceutical compositions and methods of use thereof to treat pancreatic enzyme insufficiency
ES2962985T3 (es) * 2017-06-15 2024-03-22 Univ Chicago Composiciones para el tratamiento del cáncer
WO2023194615A1 (en) * 2022-04-07 2023-10-12 Need4Health B.V. Method for determining insulin dosage

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0341503A2 (en) * 1988-05-13 1989-11-15 Stabra AG Cross-linked glucose isomerase

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3664926A (en) 1970-02-26 1972-05-23 Merck & Co Inc Crystallization of l-asparaginase
DE2857828C2 (ro) 1977-01-27 1990-06-07 Toyo Soda Mfg. Co., Ltd., Shinnanyo, Yamaguchi, Jp
US4373023A (en) * 1980-10-14 1983-02-08 Massachusetts Institute Of Technology Process for neutralizing heparin
EP0092829B1 (en) * 1982-04-23 1990-11-07 Wako Pure Chemical Industries, Ltd. Process for semi-synthesis of human insulin and alkaline protease for use therein
US4411996A (en) * 1982-06-30 1983-10-25 Nabisco Brands, Inc. Process for isomerizing glucose
EP0168487A1 (en) * 1984-01-20 1986-01-22 Eye Products Limited Partnership Method for cleaning contact lenses
FR2566798B1 (fr) * 1984-06-27 1986-12-12 Centre Nat Rech Scient Membrane porteuse de la luciferase pour le dosage de l'atp et son procede de production
US4650758A (en) * 1984-09-21 1987-03-17 Cetus Corporation Stabilization of enzymes useful in the production of glucosone and other enzymatic processes
JPS6317691A (ja) * 1986-07-09 1988-01-25 Agency Of Ind Science & Technol アスパルテ−ム製造用固定化酵素

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0341503A2 (en) * 1988-05-13 1989-11-15 Stabra AG Cross-linked glucose isomerase

Non-Patent Citations (52)

* Cited by examiner, † Cited by third party
Title
[10] Klibanov A.M., Acc. Chem.Res. vol. 23:114-120 (1990). *
[11] Nagasava T. şi Yamada H., Trends in Biotechnology, vol. 7:153-158 (1989). *
[12] Hall, "BIOSENSORS" Open University Pres, 1990. *
[13] Klein M. şi Langer R., Trends in Biotechnology 4:153-158 (1986). *
[14] Akiyama şi alţii., CHEMTEHCH 627-634 (1988). *
[15] Hartmeier, W., Trends in Biotechnology 3:149-153 (1985). *
[16] Lerner, R.A. Bencovic, S.G. şi Shultz, P.G. Science 252:629-667 (1991). *
[17] Cehc T.R. Cell 64:667-669 (1991); Celender D.V., şi Cehc T.R., Science, 251:401-407 (191). *
[18] Lindberg G.T., Chem ed, 64:1062-1064 (1987). *
[19] Cooper T.G., The Fools of Biochemistry, p.p. 379-380 (ediţia) John Wiley and Sons NY (1977). *
[2] Tüchsen E, and Ottesen M., Carlsberg Res. Comm., vol.42:407-420 (1997). *
[20] Blake C.C. şi a Nature, 196:1173 (1862). *
[21] Colman P.M., Jansonius J.H., şi Mettews J. Mol. Biol. 70:701-724 (1972). *
[22] Quiocho F.A. and Richards F.M. Biochemistry 5:4062-4076 (1976). *
[23] Feeder J. şi Schuck, J.M. Biochemistry 9:2784-2791 (1970). *
[24] Programa "Multifit 2.0 Ajustarea curbei" pentru computerul Mackintosh, Day Computing P.O. Box 327, Milton, Cambridge, CB4, 6WL, U.K. (1990). *
[25] Calbiochem 1990 Catalog LaJolla, CA. *
[26] Maugh T.H., Science 223:474-476 (1984). *
[27] Tramper J. Trends in Biotechnology 3:45-50 (1985). *
[28] Bietet al., Biochem. Med. 11:350-357 (1974). *
[29] Blake et al., (Nature, 196:1173 (1962)). *
[3] Lee K. M. et al., Bioorganic Chem., vol.14:202-210 (1986). *
[30] Vang Y şi Hamaguchi, K.J. Biochem, 8:103-104 (1980). *
[31] Grabner şi al., SU Patent 2, 664, 926 (1972). *
[32] Holms şi Mattews, J. Mol. Biol. 160:623-639 (1982). *
[33] Nakanishi et al., Biotechnology 3:459-464 (1985). *
[34] Quiochio şi Richards. Proc. Natl. Acad. Sci. (S.U.A.) 52:833-839 (1964). *
[35] Sawyer L. et al., J. Mol. Biol. 118:137-208. *
[36] Catalogul Companiei Pierce Chemical (1990). *
[37] Holms and Matthews, J. Mol. Biol. 160:623-630 (1982). *
[38] Lindberg G.T., Chem ed, 64:1062+1064 (1987). *
[39] Cyama şi alţii, Methods in Enzymol 136:503-516 (1987). *
[4] Haas D. J. et al., Biophys. J., vol.8:549-555 (1988). *
[40] Nagasawa ş.a. Biochem. Biophys. Bes. Comun. 139:1305.1213 (1986). *
[41] Isowa et al., US 4436925 (1984). *
[42] Oyama şi al., J. Ord. Chem. 46:5242:5244 (1981). *
[43] Nagasawa ş.a., Eur. I. Biochem. 162:691-698 (1987). *
[44] Bernstein ş.a., Methods in Enzimology 137:515-529 (1987). *
[45] Langer ş.a. Science 217:261-263 (1982). *
[46] Barzane E., Klibanov A. şi Karill M., NASA Tehn. Brief. 13:104 (1989). *
[47] Janata ş.a. Anal. Chem. 63:33R-44R (1990). *
[48] Kurkijarvi ş.a. Methods in Enzimol, 137:171-181 (1988). *
[49] Swanson ş.al., J. Biol. Chem. 260:1287-1289 (1985). *
[5] Yonath A. et al., Biochemistry, vol.16:1413-1417 (1977). *
[50] Persichetti R.A. et al., J. Am. Chem. Soc. 117:2732-2737 (1995). *
[51] ChiroCLEC™ -PC Information Booklet, Version 1.0, September 20, 1995, pp. 26-27. *
[52] ChiroCLEC™ -BL Information Booklet, Version 1.o, March 29, 1995, p. 25-26. *
[53] ChiroCLEC™ -CR Information Booklet, Version 2.0., September 20, 1995, pp. 33-34. *
[6] Jones T.B. Tetrahedron, vol. 42:3351-3403 (1986). *
[7] Zacs et al., Trends in Biotechnology, vol. 6; 272-275 (1988). *
[8] Wong C.-H. Science, vol.244:1145-1152 (1969). *
[9] CHEMTRACTS - Org.cEMI.vol. 3:91-111 (1990). *

Also Published As

Publication number Publication date
HU211521A9 (en) 1995-11-28
SK5993A3 (en) 1993-07-07
ES2263187T3 (es) 2006-12-01
ATE323158T1 (de) 2006-04-15
DE69133521D1 (de) 2006-05-24
EP0550450A1 (en) 1993-07-14
LV10304A (lv) 1994-10-20
HK1023362A1 (en) 2000-09-08
CA2087730A1 (en) 1992-02-04
IL99046A (en) 1998-09-24
DE69133258D1 (de) 2003-06-18
JPH05508549A (ja) 1993-12-02
PT98564A (pt) 1992-06-30
UA27035C2 (uk) 2000-02-28
LV10304B (en) 1995-06-20
DK0861888T3 (da) 2006-08-14
TJ210R3 (en) 1998-11-14
ATE240391T1 (de) 2003-05-15
NO930360D0 (no) 1993-02-02
LT3366B (en) 1995-07-25
AU8315491A (en) 1992-03-02
RU2124052C1 (ru) 1998-12-27
EP0861888B1 (en) 2006-04-12
HU9300275D0 (en) 1993-04-28
WO1992002617A1 (en) 1992-02-20
EP0550450B1 (en) 2003-05-14
SK283185B6 (sk) 2003-03-04
AU662104B2 (en) 1995-08-24
JP2004000230A (ja) 2004-01-08
EP0861888A1 (en) 1998-09-02
SG70966A1 (en) 2000-03-21
HK1012411A1 (en) 1999-07-30
FI930454A0 (fi) 1993-02-02
BR9106732A (pt) 1993-08-17
FI930454A (fi) 1993-02-02
FI120099B (fi) 2009-06-30
DE69133521T2 (de) 2006-12-07
HUT65904A (en) 1994-07-28
ES2199933T3 (es) 2004-03-01
CZ12393A3 (en) 1993-10-13
CA2087730C (en) 1999-07-20
PT98564B (pt) 1999-01-29
IE20040113A1 (en) 2004-05-05
NO930360L (no) 1993-04-02
DE69133258T2 (de) 2004-03-18
IE912767A1 (en) 1992-02-12
LTIP1077A (en) 1995-04-25
IL99046A0 (en) 1992-07-15
DK0550450T3 (da) 2003-09-08

Similar Documents

Publication Publication Date Title
MD1592B2 (ro) Cristale de enzimă reticulate şi aplicarea lor în dispozitiv extracorporal, în biosensor şi pentru obţinerea produsului selectat
Fontana et al. Identification of a streptococcal penicillin-binding protein that reacts very slowly with penicillin
Shockman et al. Autolytic Enzyme System of Streptococcus faecalis III. Localization of the Autolysin at the Sites of Cell Wall Synthesis
ATE317848T1 (de) Unterbrochene 2'-modifizierte oligonukleotide
ES8700270A1 (es) Un metodo para producir nucleotidos.
DE69710087T2 (de) Verwendung von modifizierter stärke aus mittel zur bildung eines thermoreversiblen gels
NO991890D0 (no) MÕls°kende diagnostiske og/eller terapeutiske aktive midler
GB1400258A (en) Glutaraldehyde sporicidal compsitions
KR910005764A (ko) 중온안정세균 알파 - 아밀라제 효소를 이용하여 빵제품의 변성을 지연시키는 방법
DE69113165T2 (de) Eine Succinoglykan enthaltende Zusammensetzung.
Marshall Preparation and characterization of a dextran-amylase conjugate
Levenson A collagen film microassay for tissue collagenase
Ramasesh et al. Purification and Characterization of a Thermophilic α‐Amylase of Aspergillus niger van Tieghem
Khan et al. Polyclonal‐antibody‐mediated insolubilization and stabilization of papain
Shvedova et al. Catalytic activity of the nucleic acid component of the 1, 4-α-glucan branching enzyme from rabbit muscles
FR2356665A1 (fr) Enzymes insolubilisees et leur preparation
JPH0775543B2 (ja) 生体触媒固定化用担体
DE1935711C3 (de) Wasserunlösliches Protein. Ausscheidung aus: 1908290
NL7708669A (nl) Werkwijze voor de selectieve inactivering van pro- teolytische enzymactiviteit in een bacterieel (alpha)- -amylase enzympreparaat en werkwijze voor de en- zymatische produktie van een zetmeelhydrolysaat.
Fukasawa et al. Properties of the Agarase from a Luminous Bacterium, Vibrio harveyi
Tangheroni et al. Characterization of platelet alkaline phosphatase in normal subjects and in trisomy 21 Down's syndrome patients
Yugari et al. Immobilization of Enzyme on PMG and Its Application to the Urea Monitoring Apparatus
WATANABE et al. Measurement of Gelatinization Properties of Sprouted Wheat with α-Amylase Inhibitors
Ohshita et al. Analysis of lysosomal degradation of fluorescein isothiocyanate-labelled proteins by Toyopearl HW-40 affinity chromatography
Roe et al. Agar gel electrophoretic demonstration of charge alteration in mutant bacterial proteins

Legal Events

Date Code Title Description
PD99 Pending application